Results of radiotherapy alone in the treatment of advanced cervix carcinoma

F. Volterrani, L. Lozza, S. Tana, N. Di Muzio

Research output: Contribution to journalArticle

Abstract

A study has been made on 429 cases of advanced stage carcinoma of the uterine cervix treated with radiotherapy alone in the years 1971/85 (105 Stage II-distal, 24.5%, 315 Stage III, 73.4%, 9 Stage IVa, 2.1%). 2 and 5-year relapse free survival (RFS) was respectively 56.3% and 48.1% for all the patients considered, with the exception of the 9 initially stage IVa cases. In the initially Stage II-distal cases, RFS was respectively 72.3% and 59.1% and, in initially stage III cases, respectively 50.1% and 43.1%. None of the Stage IVa patients survived without relapse beyond two years from the treatment. The most frequent failure cause was lack of pelvic control, mainly alone or, more seldom, in association with distant metastasis. In the years 1980/85, 168 patients (39.2%) were submitted to irradiation techniques conforming with the modern requirements of radiotherapy of cervical cancer (whole pelvis external irradiation with high power megavoltage machines plus central boost with remote-loading curietherapy). There was a considerable improvement in the results for the Stage II-distal cases. The 5-year NED survival was 66.5%, with respect to the 52.0% observed for the cases treated in the years 1971/79. Lack of pelvic control was reduced by about 1/3, and the number of pelvic relapses with central recurrence was more than halved. On the contrary, a minimum improvement was achieved for Stage III. RFS remained unaltered around 50% at 5 years, the lack of pelvic control was only slightly reduced and the number of pelvic relapses with central recurrence was unchanged. Radiotherapy is still the basic treatment for advanced stage cervical carcinoma. The classical methods to improve its results (irradiation in hyperbarism, hyperthermia, high LET radiations, radiosensitizers, interstitial parametrial implants) have not produced convincing results up to now, or are still at a preliminary study phase. Attention is now drawn to the addition of chemotherapy given prior to radiotherapy (neoadjuvant chemotherapy) or in strict synchronization (concurrent chemo-radiotherapy).

Original languageEnglish
Pages (from-to)177-185
Number of pages9
JournalCervix and the Lower Female Genital Tract
Volume8
Issue number2
Publication statusPublished - 1990

Fingerprint

Cervix Uteri
Radiotherapy
Carcinoma
Recurrence
Survival
Therapeutics
Pelvic Neoplasms
Linear Energy Transfer
Drug Therapy
Brachytherapy
Uterine Cervical Neoplasms
Fever
Radiation
Neoplasm Metastasis

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Results of radiotherapy alone in the treatment of advanced cervix carcinoma. / Volterrani, F.; Lozza, L.; Tana, S.; Di Muzio, N.

In: Cervix and the Lower Female Genital Tract, Vol. 8, No. 2, 1990, p. 177-185.

Research output: Contribution to journalArticle

@article{6adf3cf492b142689515ef4af61ce90c,
title = "Results of radiotherapy alone in the treatment of advanced cervix carcinoma",
abstract = "A study has been made on 429 cases of advanced stage carcinoma of the uterine cervix treated with radiotherapy alone in the years 1971/85 (105 Stage II-distal, 24.5{\%}, 315 Stage III, 73.4{\%}, 9 Stage IVa, 2.1{\%}). 2 and 5-year relapse free survival (RFS) was respectively 56.3{\%} and 48.1{\%} for all the patients considered, with the exception of the 9 initially stage IVa cases. In the initially Stage II-distal cases, RFS was respectively 72.3{\%} and 59.1{\%} and, in initially stage III cases, respectively 50.1{\%} and 43.1{\%}. None of the Stage IVa patients survived without relapse beyond two years from the treatment. The most frequent failure cause was lack of pelvic control, mainly alone or, more seldom, in association with distant metastasis. In the years 1980/85, 168 patients (39.2{\%}) were submitted to irradiation techniques conforming with the modern requirements of radiotherapy of cervical cancer (whole pelvis external irradiation with high power megavoltage machines plus central boost with remote-loading curietherapy). There was a considerable improvement in the results for the Stage II-distal cases. The 5-year NED survival was 66.5{\%}, with respect to the 52.0{\%} observed for the cases treated in the years 1971/79. Lack of pelvic control was reduced by about 1/3, and the number of pelvic relapses with central recurrence was more than halved. On the contrary, a minimum improvement was achieved for Stage III. RFS remained unaltered around 50{\%} at 5 years, the lack of pelvic control was only slightly reduced and the number of pelvic relapses with central recurrence was unchanged. Radiotherapy is still the basic treatment for advanced stage cervical carcinoma. The classical methods to improve its results (irradiation in hyperbarism, hyperthermia, high LET radiations, radiosensitizers, interstitial parametrial implants) have not produced convincing results up to now, or are still at a preliminary study phase. Attention is now drawn to the addition of chemotherapy given prior to radiotherapy (neoadjuvant chemotherapy) or in strict synchronization (concurrent chemo-radiotherapy).",
author = "F. Volterrani and L. Lozza and S. Tana and {Di Muzio}, N.",
year = "1990",
language = "English",
volume = "8",
pages = "177--185",
journal = "Cervix and the Lower Female Genital Tract",
issn = "0393-3512",
number = "2",

}

TY - JOUR

T1 - Results of radiotherapy alone in the treatment of advanced cervix carcinoma

AU - Volterrani, F.

AU - Lozza, L.

AU - Tana, S.

AU - Di Muzio, N.

PY - 1990

Y1 - 1990

N2 - A study has been made on 429 cases of advanced stage carcinoma of the uterine cervix treated with radiotherapy alone in the years 1971/85 (105 Stage II-distal, 24.5%, 315 Stage III, 73.4%, 9 Stage IVa, 2.1%). 2 and 5-year relapse free survival (RFS) was respectively 56.3% and 48.1% for all the patients considered, with the exception of the 9 initially stage IVa cases. In the initially Stage II-distal cases, RFS was respectively 72.3% and 59.1% and, in initially stage III cases, respectively 50.1% and 43.1%. None of the Stage IVa patients survived without relapse beyond two years from the treatment. The most frequent failure cause was lack of pelvic control, mainly alone or, more seldom, in association with distant metastasis. In the years 1980/85, 168 patients (39.2%) were submitted to irradiation techniques conforming with the modern requirements of radiotherapy of cervical cancer (whole pelvis external irradiation with high power megavoltage machines plus central boost with remote-loading curietherapy). There was a considerable improvement in the results for the Stage II-distal cases. The 5-year NED survival was 66.5%, with respect to the 52.0% observed for the cases treated in the years 1971/79. Lack of pelvic control was reduced by about 1/3, and the number of pelvic relapses with central recurrence was more than halved. On the contrary, a minimum improvement was achieved for Stage III. RFS remained unaltered around 50% at 5 years, the lack of pelvic control was only slightly reduced and the number of pelvic relapses with central recurrence was unchanged. Radiotherapy is still the basic treatment for advanced stage cervical carcinoma. The classical methods to improve its results (irradiation in hyperbarism, hyperthermia, high LET radiations, radiosensitizers, interstitial parametrial implants) have not produced convincing results up to now, or are still at a preliminary study phase. Attention is now drawn to the addition of chemotherapy given prior to radiotherapy (neoadjuvant chemotherapy) or in strict synchronization (concurrent chemo-radiotherapy).

AB - A study has been made on 429 cases of advanced stage carcinoma of the uterine cervix treated with radiotherapy alone in the years 1971/85 (105 Stage II-distal, 24.5%, 315 Stage III, 73.4%, 9 Stage IVa, 2.1%). 2 and 5-year relapse free survival (RFS) was respectively 56.3% and 48.1% for all the patients considered, with the exception of the 9 initially stage IVa cases. In the initially Stage II-distal cases, RFS was respectively 72.3% and 59.1% and, in initially stage III cases, respectively 50.1% and 43.1%. None of the Stage IVa patients survived without relapse beyond two years from the treatment. The most frequent failure cause was lack of pelvic control, mainly alone or, more seldom, in association with distant metastasis. In the years 1980/85, 168 patients (39.2%) were submitted to irradiation techniques conforming with the modern requirements of radiotherapy of cervical cancer (whole pelvis external irradiation with high power megavoltage machines plus central boost with remote-loading curietherapy). There was a considerable improvement in the results for the Stage II-distal cases. The 5-year NED survival was 66.5%, with respect to the 52.0% observed for the cases treated in the years 1971/79. Lack of pelvic control was reduced by about 1/3, and the number of pelvic relapses with central recurrence was more than halved. On the contrary, a minimum improvement was achieved for Stage III. RFS remained unaltered around 50% at 5 years, the lack of pelvic control was only slightly reduced and the number of pelvic relapses with central recurrence was unchanged. Radiotherapy is still the basic treatment for advanced stage cervical carcinoma. The classical methods to improve its results (irradiation in hyperbarism, hyperthermia, high LET radiations, radiosensitizers, interstitial parametrial implants) have not produced convincing results up to now, or are still at a preliminary study phase. Attention is now drawn to the addition of chemotherapy given prior to radiotherapy (neoadjuvant chemotherapy) or in strict synchronization (concurrent chemo-radiotherapy).

UR - http://www.scopus.com/inward/record.url?scp=0025178964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025178964&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025178964

VL - 8

SP - 177

EP - 185

JO - Cervix and the Lower Female Genital Tract

JF - Cervix and the Lower Female Genital Tract

SN - 0393-3512

IS - 2

ER -